← Back to all trials
Completed
NCT07816900
Efficacy and Safety of Da-Cheng-Qi Decoction in Severe Acute Pancreatitis
Conditions: Severe Acute Pancreatitis, Intra-abdominal Hypertension
Sex: All
Ages: 18 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 60
Sponsor: Shanghai Jiao Tong University School of Medicine
Location: Emergency Department, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai
Summary
This single-center prospective randomized controlled trial evaluated Da-Cheng-Qi Decoction (DCQD) as the acute-stage intervention of an integrated traditional Chinese and Western medicine whole-stage treatment protocol for severe acute pancreatitis (SAP). Sixty adults with SAP and intra-abdominal hypertension (IAP ≥ 12 mmHg) were randomized within 72 h of onset to receive standard Western treatment plus DCQD (100 mL via nasogastric tube twice daily for 7 days) or standard Western treatment alone. The primary outcome was intra-abdominal pressure measured by standardized bladder manometry every 12 h for 7 days. Secondary outcomes included stool output, length of hospital and ICU stay, and 28-day mortality. The trial was conducted at the Emergency Intensive Care Unit of Ruijin Hospital between April 2026 and July 2026.
Eligibility Criteria
Inclusion Criteria:
* Severe acute pancreatitis diagnosed according to the revised Atlanta classification
* Age 18-80 years
* Disease onset within 72 h
* Intra-abdominal hypertension (IAP \>= 12 mmHg) within 24 h of admission
* Written informed consent obtained
Exclusion Criteria:
* Age \80 years
* Pregnancy or lactation
* Advanced malignancy (pancreatic, hepatobiliary, or gastrointestinal)
* Severe chronic organ failure
* Autoimmune disease or immunosuppression
* Intra-abdominal hemorrhage
* Urinary tract infection or prior bladder surgery (precluding bladder manometry)
* Allergic constitution or known allergy to study medication
* Psychiatric illness
Source: ClinicalTrials.gov (NCT07816900). StuddyBuddy aggregates publicly available trial information.